Evidence map›Paper›PMID 39463133›Full record

ArticleCancer reports (Hoboken, N.J.)2024

Assessing the Concordance of Clinical and Pathological Diagnoses in Basal Cell Carcinoma Among the Iranian Population: A Cross-Sectional Analysis of 229 Cases.

Fatemeh Farshad, Elham Behrangi, Alireza Jafarzadeh, Masoumeh Roohaninasab, Nasrin Shayanfar, Zeinab Aryanian, Parvaneh Hatami, Azadeh Goodarzi

Abstract read
In one paragraph

Article in Cancer reports (Hoboken, N.J.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fatemeh FarshadSchool of Medicine, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-5592-7394
Elham BehrangiDepartment of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-6545-3460
Alireza JafarzadehDepartment of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-5878-9778
Masoumeh RoohaninasabDepartment of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-2862-6422
Nasrin ShayanfarDepartment of Dermatopathology, Rasool Akram Medical Complex, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-8599-1402
Zeinab AryanianAutoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-7077-1458
Parvaneh HatamiAutoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-3531-2907
Azadeh GoodarziDepartment of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-1249-4429

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNonmelanoma skin cancer (NMSC) is the most prevalent malignancy globally, with basal cell carcinoma (BCC) being the most common type.

aimsThis study aims to evaluate the concordance between clinical and pathological diagnoses of BCC, emphasizing the importance of early detection. METHODS AND

resultsIn this cross-sectional study, we conducted a retrospective review of clinical and pathological records for 229 patients diagnosed with BCC between 2020 and 2024. The analysis focused on gender, age, lesion location, and diagnostic accuracy. Among the 229 patients, 193 were men (84.3%), and 131 (57.2%) had recorded clinical diagnoses. The mean age of diagnosed patients was 67.72 years. Lesions were primarily located on the scalp (29.5%), face (26.4%), and nose (13.9%). Of the pathological evaluations, 184 cases (80.3%) confirmed BCC, while 45 cases had alternative diagnoses. Notably, 94.6% of clinically diagnosed patients were suspected to have BCC by their physicians. A significant portion of cases (42%) lacked prior clinical diagnoses, reflecting a potential gap in education among nondermatologists regarding BCC recognition.

conclusionThe study found high concordance between clinical and pathological diagnoses of BCC, underscoring the need for improved clinical assessment skills among healthcare providers. Collaboration with dermatologists is essential for accurate diagnosis and improved patient outcomes. Enhanced training in recognizing BCC symptoms is recommended to address the identified gaps in clinical suspicion.

Indexed as

Basal Cell CarcinomaSkin NeoplasmsAdultAgedAged, 80 and overCross-Sectional StudiesFemaleHumansIranMaleMiddle AgedRetrospective Studiesclinical assessmentdiagnostic accuracyhistopathological findingsreferral patternsskin cancer education

Identifiers

PMID39463133
PMCPMC11513546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.